Biostime’s newest product features probiotic strains Bifidobacterium longum CECT 7894 and Pediococcus pentosaceus CECT 8330.
Biostime, a brand of children’s probiotic and prebiotic supplements, has selected trademarked probiotic strains Bifidobacterium longum CECT 7894 and Pediococcus pentosaceus CECT 8330 for its latest children’s probiotic supplement. The strains are supplied by Kaneka Probiotics (Pasadena, TX) and AB-Biotics (Barcelona). Kaneka Probiotics is a shareholder in AB-Biotics and licenses, produces, and distributes AB-Biotics ingredients in certain countries.
Biostime is a brand of H&H Group that markets probiotic products that support digestion, gastrointestinal discomfort, immunity, teeth, and bone health. Its latest product, Biostime Vitamin D + Probiotic drops, is designed to support healthy gut microbiota in infants from 0 to 3 years of age, and is available in the U.S. and Asia.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.